|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1998-8-17
|
|
pubmed:abstractText |
Differential diagnosis of adenocarcinoma from other proliferative conditions in the prostate is often problematic. Immunohistochemistry using an antibody (34 beta E12) to high molecular weight cytokeratin, specifically present in basal cells of the prostate, could clearly demonstrate the presence or absence of these cells in the proliferating glands and thus provide an important clue in cancer diagnosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0919-8172
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
237-42
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9624554-Adenocarcinoma,
pubmed-meshheading:9624554-Aged,
pubmed-meshheading:9624554-Aged, 80 and over,
pubmed-meshheading:9624554-Antibodies, Monoclonal,
pubmed-meshheading:9624554-Diagnosis, Differential,
pubmed-meshheading:9624554-Evaluation Studies as Topic,
pubmed-meshheading:9624554-Humans,
pubmed-meshheading:9624554-Immunohistochemistry,
pubmed-meshheading:9624554-Keratins,
pubmed-meshheading:9624554-Male,
pubmed-meshheading:9624554-Middle Aged,
pubmed-meshheading:9624554-Molecular Weight,
pubmed-meshheading:9624554-Prostatic Neoplasms
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Utility of immunohistochemical detection of high molecular weight cytokeratin for differential diagnosis of proliferative conditions of the prostate.
|
|
pubmed:affiliation |
Department of Pathology, Osaka University Medical School, Suita, Japan.
|
|
pubmed:publicationType |
Journal Article
|
